Politicising the pandemic: what are the consequences of Trump’s rhetoric?
President Trump’s handling of the Covid-19 outbreak in the US has been widely criticised. Over...
US election: where do the candidates stand on non-Covid healthcare issues?
Covid-19 is not the only healthcare area of interest to Americans in this election; the...
Twist and Neogene partner to develop next-gen T cell therapies
Twist Bioscience will be supporting Neogene to develop novel, personalised T cell therapies with its...
US election: where do the candidates stand on Covid-19 response?
Unsurprisingly, Covid-19 is dominating the agenda in this US election, with Donald Trump defending his...
Exscientia, Blue Oak partner to explore potential of bispecific drugs in CNS
Exscientia is partnering with Blue Oak to develop new bispecific drugs for CNS diseases. How...
Spotlight on rare NMOSD: Chord launches with $16m Series A round
Omega Funds has backed Chord Therapeutics with $16m Series A funding. This money will be...
Targeting PP2A to tackle cancers: Rappta closes €9m Series A round
PP2A has long been recognised as a promising target in oncology, but it has remained...
Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough?
Different from a gluten intolerance, coeliac disease causes long-term damage to patients’ small intestine and...
The road to Covid-19 recovery in the US: what role will vaccines play?
Everbridge invited representatives from the US CDC and National Institutes of Health to its recent...